These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1687390

  • 1. Evaluation of dopamine receptor involvement in rat feeding behaviour.
    Zarrindast MR, Owji AA, Hosseini-Nia T.
    Gen Pharmacol; 1991; 22(6):1011-6. PubMed ID: 1687390
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR, Eliassi A.
    Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
    [Abstract] [Full Text] [Related]

  • 3. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR, Minaian A.
    Gen Pharmacol; 1991; 22(6):1017-21. PubMed ID: 1687391
    [Abstract] [Full Text] [Related]

  • 4. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P, Broekkamp CL, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [Abstract] [Full Text] [Related]

  • 5. Involvement of dopaminergic receptor subtypes in straub tail behaviour in mice.
    Zarrindast MR, Bayat A, Shafaghi B.
    Gen Pharmacol; 1993 Jan; 24(1):127-30. PubMed ID: 8097737
    [Abstract] [Full Text] [Related]

  • 6. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR, Tabatabai SA.
    Psychopharmacology (Berl); 1992 Jan; 107(2-3):341-6. PubMed ID: 1535446
    [Abstract] [Full Text] [Related]

  • 7. Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.
    Zarrindast MR, Habibi-Moini S.
    Gen Pharmacol; 1991 Jan; 22(6):1023-6. PubMed ID: 1687392
    [Abstract] [Full Text] [Related]

  • 8. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.
    Nunes JL, Sharif NA, Michel AD, Whiting RL.
    Neurochem Res; 1991 Oct; 16(10):1167-74. PubMed ID: 1686637
    [Abstract] [Full Text] [Related]

  • 9. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 10. Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats.
    Gilbert DB, Cooper SJ.
    Brain Res Bull; 1985 Oct 28; 15(4):385-9. PubMed ID: 2933127
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of D1 and D2 dopamine receptors produces additive anorectic effects.
    Ladurelle N, Duterte-Boucher D, Costentin J.
    Fundam Clin Pharmacol; 1991 Oct 28; 5(6):481-90. PubMed ID: 1683341
    [Abstract] [Full Text] [Related]

  • 12. Role of D-1 and D-2 receptors in apomorphine-induced pecking in chicks.
    Zarrindast MR, Amin R.
    Psychopharmacology (Berl); 1992 Oct 28; 106(1):67-70. PubMed ID: 1346722
    [Abstract] [Full Text] [Related]

  • 13. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N, Nagao T, Ono H.
    Neuropharmacology; 1993 Aug 28; 32(8):777-83. PubMed ID: 8105410
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 15. Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
    Zarrindast MR, Shahed-Dirin K.
    Psychopharmacology (Berl); 1990 Feb 07; 100(2):275-80. PubMed ID: 2305016
    [Abstract] [Full Text] [Related]

  • 16. Opposite influences of dopaminergic receptor subtypes on penile erection.
    Zarrindast MR, Shokravi S, Samini M.
    Gen Pharmacol; 1992 Jul 07; 23(4):671-5. PubMed ID: 1356874
    [Abstract] [Full Text] [Related]

  • 17. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM, Fernández M, Jantos H.
    Neuropsychopharmacology; 1990 Jun 07; 3(3):153-62. PubMed ID: 2141985
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW, Qin ZH, Weiss B.
    Neuropsychopharmacology; 1991 Jan 07; 4(1):47-55. PubMed ID: 1672250
    [Abstract] [Full Text] [Related]

  • 19. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 07; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD, de Ceballos ML, Jenner P, Marsden CD.
    Biochem Pharmacol; 1991 May 01; 41(9):1385-91. PubMed ID: 1673340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.